We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.25B
AUM Growth
+$53.9M
Cap. Flow
-$10.8M
Cap. Flow %
-0.87%
Top 10 Hldgs %
26.05%
Holding
317
New
17
Increased
127
Reduced
146
Closed
10

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$14.2M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$5.55M
3
AMZN icon
Amazon
AMZN
+$1.99M
4
AAPL icon
Apple
AAPL
+$1.82M
5
MZTI
The Marzetti Company
MZTI
+$960K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.38%
2 Technology 17.31%
3 Healthcare 12.84%
4 Consumer Staples 10.16%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNDX icon
101
Vanguard Total International Bond ETF
BNDX
$82.5B
$3.44M 0.28%
59,054
+12,600
+27% +$731K
FDX icon
102
FedEx
FDX
$78.3B
$3.44M 0.28%
13,656
-180
-1% -$36K
LDOS icon
103
Leidos
LDOS
$17.7B
$3.43M 0.28%
38,444
+30
+0.1% +$2.71K
VWO icon
104
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$3.39M 0.27%
78,312
-2,133
-3% -$92.7K
C icon
105
Citigroup
C
$223B
$3.36M 0.27%
77,912
-1,923
-2% -$95.8K
MDT icon
106
Medtronic
MDT
$117B
$3.35M 0.27%
32,201
+1,390
+5% +$140K
WFC icon
107
Wells Fargo
WFC
$262B
$3.15M 0.25%
134,074
-14,046
-9% -$346K
NOC icon
108
Northrop Grumman
NOC
$77.5B
$3.07M 0.25%
9,719
-44
-0.5% -$14.3K
VNQ icon
109
Vanguard Real Estate ETF
VNQ
$38.6B
$3.04M 0.24%
38,474
+8,819
+30% +$708K
VO icon
110
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$3.02M 0.24%
68,512
+7,544
+12% +$329K
IVV icon
111
iShares Core S&P 500 ETF
IVV
$898B
$2.99M 0.24%
8,908
+163
+2% +$54.2K
GILD icon
112
Gilead Sciences
GILD
$181B
$2.96M 0.24%
46,922
-967
-2% -$67.1K
IWF icon
113
iShares Russell 1000 Growth ETF
IWF
$126B
$2.96M 0.24%
54,664
-212
-0.4% -$11.2K
EFV icon
114
iShares MSCI EAFE Value ETF
EFV
$31.6B
$2.92M 0.23%
72,340
-3,553
-5% -$147K
KMB icon
115
Kimberly-Clark
KMB
$36.4B
$2.91M 0.23%
19,707
-258
-1% -$38.7K
TRV icon
116
Travelers Companies
TRV
$77.2B
$2.88M 0.23%
26,643
-640
-2% -$73.4K
BSV icon
117
Vanguard Short-Term Bond ETF
BSV
$45.6B
$2.85M 0.23%
34,311
+7,837
+30% +$651K
VHT icon
118
Vanguard Health Care ETF
VHT
$19.3B
$2.85M 0.23%
13,946
-998
-7% -$202K
AMAT icon
119
Applied Materials
AMAT
$366B
$2.8M 0.22%
47,108
+1,346
+3% +$83.1K
ELV icon
120
Elevance Health
ELV
$85.5B
$2.8M 0.22%
10,426
+112
+1% +$30.1K
AVGO icon
121
Broadcom
AVGO
$1.75T
$2.8M 0.22%
76,810
+5,910
+8% +$198K
CVX icon
122
Chevron
CVX
$396B
$2.78M 0.22%
38,633
-3,461
-8% -$291K
BND icon
123
Vanguard Total Bond Market
BND
$161B
$2.75M 0.22%
31,196
+6,106
+24% +$541K
TJX icon
124
TJX Companies
TJX
$149B
$2.74M 0.22%
49,249
-735
-1% -$39.6K
CTSH icon
125
Cognizant
CTSH
$28.8B
$2.68M 0.21%
38,573
+831
+2% +$54.1K

Similar funds

Dowling & Yahnke's Q3 2020 Portfolio in Review

As of Q3 2020, Dowling & Yahnke held 317 positions worth $1.25B, up 4.5% from $1.19B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q3 2020 filing shows 17 new, 127 increased, 146 reduced and 10 closed positions. Its largest new stake was Schrodinger: 9,828 shares worth $467K. The largest sale was DexCom, an estimated $14.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q3 2020 buy was Schrodinger: 9,828 shares worth $467K.
  • Dowling & Yahnke added most to Vanguard Emerging Markets Government Bond ETF in Q3 2020, an estimated $2.91M increase.
  • Dowling & Yahnke's biggest Q3 2020 reduction was DexCom, cutting an estimated $14.2M.
  • Dowling & Yahnke fully exited First Trust Enhanced Short Maturity ETF in Q3 2020, selling an estimated $580K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $1.25B portfolio in Q3 2020.
  • Dowling & Yahnke opened 17 new positions and closed 10 in Q3 2020.
  • Dowling & Yahnke's portfolio value rose 4.5% quarter-over-quarter to $1.25B.

Based on Dowling & Yahnke's 13F filing for Q3 2020, filed 19 Oct 2020.